Skip to content
ONIX logo blue
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Contact
ONIX logo blue
Contact
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
Menu
  • HOME
  • ABOUT
    • TEAM
  • SERVICES
    • eCTD Submission Management Services
    • Regulatory Advisory Services
    • eCTD MS Word & PDF Formatting
    • eCTD Template Automation
    • Regulatory Affairs Services
    • eSUBMISSION – Expertise
  • eCTD NEWS
    • Testimonials
etch weekly update image

eCTD Industry Update (2nd May 2023)

May 2, 2023
/
onix

EMA

  • Template or form: CHMP protocol assistance scientific advice briefing document template (updated)
  • Newsletter: News bulletin for small and medium-sized enterprises - Issue 58
  • Regulatory and procedural guideline: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes / Clean Version (updated)
  • Regulatory and procedural guideline: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes / Clean Version (updated)
  • Extensions of marketing authorisations: questions and answers (updated)
  • Pre-authorisation guidance (updated)

eSubmissions (eCTD)

Web-based Human Variations eAF (DADI) - Updated timeline

We are pleased to inform you the updated PLM (Product Lifecycle Management) Portal web-based electronic Application Form (eAF) for Human medicinal products release timeline is available on the PLM portal Forum at the following link. In addition, we invite PLM Portal users' feedback on the Portal and web-based eAFs through a survey you can find below.

Note in particular the following periods:

June 2023 Start of data transfer - Centrally Authorised Products (CAPs) and Nationally Authorised Products (NAPs) for use in eAFs - the first NAPs products will appear in the eAF. This will allow users to start preparing web-based eAFs for NAPs as these products become gradually available on the PLM Portal;
August 2023 Expected completion of data transfer - all CAPs and NAPs available in eAF;
November 2023 User Acceptance Testing (UAT) on the version of the web-based eAF intended to replace the PDF and trigger the transition;
Q1 2024 Confirmation of transition period start date, approximately 2 months in
Q2 2024 Start of 6-months transition to mandatory use of web-based eAF for Human Variations. This is subject to a successful outcome of the UAT. Note that the transition period may start earlier, if feasible, respecting the 2- month advance notice period.

(Further detailed information on impacts for eAF Users, can be found in the 2nd page of the document link.

Please note:

  • Functionalities required for mandatory use are being released incrementally: all required functionalities will be available on the PLM Portal before the start of the UAT.
  • The use of the web-based eAF will follow the current process for updating data. Use of structured data will be implemented at a later point.
  • The capability to view migrated PMS product data in the Product User Interface on the PLM Portal is under development in parallel - delivery timelines will be announced at a later date.
  • Details on how the UAT will be organized will be shared in due course.

Feedback Survey for PLM Portal Users (New Deadline: 8 May 2023)

We kindly ask you to provide your feedback on your experience with the new eAF and the PLM Portal, by responding the survey at the following link: https://ec.europa.eu/eusurvey/runner/Adoption-survey-eAF-HumanVariations

This survey aims to gather your feedback on the level of adoption of the change, including the potential concerns or issues you are facing, in order to enable the eAF product team to envisage appropriate fixing and/or mitigation activities.

Please note that the survey will be anonymous, and the results will not be publicly disclosed. This survey was already shared with PLM portal users in March 2023 and was intended to close on 31 March 2023, but the deadline for responding is now extended to 8 May 2023.

For more insight on eAF, you are invited to consult the following Q&A documents and sessions:

  • eAF-PMS FAQs Document (link), including Q&A's on PMS (Product Management Services);
  • Training Q&A document (link) addressing questions raised by users during earlier eAF (DADI) trainings;
  • Human Variations eAF go-live Q&A session (link);
  • Human Variations eAF go-live training session (2 February 2023) (link).

eSubProgofficer@ema.europa.eu or via the PLM Portal Forum.

MHRA

  • Regulating medical devices in the UK
  • Register medical devices to place on the market

SwissMedic

  • Changes to the forms for new authorisations of and variations to human and veterinary medicinal products
  • Changes to the guidance document GMP compliance by foreign manufacturers and the form Declaration by the Responsible Person for foreign manufacturers
  • Modification of the DMF form
PreveCTD Industry Update (25th April 2023)
eCTD Industry Update (9th May 2023)Next
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Menu
  • HOME
  • ABOUT
  • SERVICES
  • eCTD NEWS
  • CONTACT
Twitter Linkedin

© Copyright 2025

ONIX Life Sciences Ltd, 59-60 Thames Street, Windsor, Berkshire, SL4 1TX.

ONIX Life Sciences Inc, 500 Delaware Ave, Ste 1 #1960, Wilmington, DE 19899, USA

ONIX Life Sciences Ltd, Salarpuria Sanctity, Kasavanahalli, Sarjapur Road, Bangalore 560035 India

+44 (0) 1753 257 904 | info@onixls.com | www.onixls.com

Privacy Policy